Paasa Logo
Prothena Corporation plc logo
PRTANASDAQMarket closedOpens 9:30am ET

Prothena Corporation plc

$8.29Last updated
-$0.03 (0.36%)Past day
Timezone

Prothena Corporation plc (NASDAQ: PRTA) is trading at $8.29, about ₹795 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 0.36% today. Indian residents can buy Prothena from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$8.33
Previous close:$8.32
Volume:481.05K

Today's low

$8.19

Today's high

$8.52

52 week low

$7.73

52 week high

$11.80

PRTA opened at $8.33, closed previously at $8.32, and has traded between $7.73 and $11.80 over the past 52 weeks.

About

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson's disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau antibody which is in Phase 2 clinical trial to treat Alzheimer's disease; PRX019, an investigational antibody which is in Phase 1 clinical trial for the treatment of neurodegenerative diseases; and PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer's disease. In addition, it develops discovery- and late-preclinical-stage programs include TDP-43 CYTOPE for the treatment of amyotrophic lateral sclerosis; PRX012, a next-generation anti-Aß antibody which is in phase 1 clinical trial to treat Alzheimer's disease; and PRX012-TfR, a preclinical program for the treatment of Alzheimer's disease. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43. Prothena Corporation plc was incorporated in 2012 and is based in Dublin, Ireland.

Country
IE
CEO
Gene G. Kinney
Exchange listed on
NASDAQ
Industry
Biotechnology
Base currency
USD
Full Time Employees
67
Sector
Healthcare
IPO date
20/12/2012

Key statistics

Avg. volume

513.21K

Market cap

$434.01M

P/E Ratio

-9.99

Price-to-sales ratio

7.96

Enterprise value

$152.81M

Free cash flow yield

-13.99%

Debt-to-equity ratio

0.02

Return on equity

-14.98%

ROIC

-21.36%

Beta

-0.33

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$9.68M

Earnings per share

-$4.53

Free cash flow

-$163.72M

Net profit margin

-80.67%

Gross margin

43.52%

EBITDA

-$197.13M

Revenue growth

-92.83%

Similar securities

This is not an investment recommendation

How to buy Prothena from India

Indian residents can buy Prothena shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Prothena and place an order

    Find Prothena by name or by its ticker, PRTA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Prothena trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Prothena position in USD and INR. Prothena pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Prothena from India

Trading and taxes when buying Prothena from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneProthena does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Prothena stock?

Yes. Prothena (PRTA) has been listed on NASDAQ since 2012, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Prothena share cost in rupees?

One Prothena share is $8.29 — about ₹795 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Prothena price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Prothena from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Prothena?

Yes. One Prothena share is $8.29, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Prothena.

How are gains on Prothena shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Prothena price. Paasa issues a capital-gains statement for your return.

Does Prothena pay a dividend?

No. Prothena does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Prothena from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is Prothena a United States company, and does that change how it is taxed?

Prothena trades on NASDAQ in US dollars, but the company is domiciled in Ireland. Prothena trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare Prothena shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Prothena holding, its cost and its closing value.

How do I sell Prothena and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.